Discover the future of cancer treatment with SEF Immuno-Chemo, a revolutionary therapy delivering successful remissions without the toxicity associated with traditional chemotherapy.
Kenneth Matsumura—the visionary who pioneered this groundbreaking cancer therapy—is now changing the landscape of treatment. His novel approach has garnered international acclaim, and is now being sought after worldwide to share his expertise. As a leading authority in the field, he is on a mission to teach medical professionals globally, ensuring that the transformative impact of his innovative therapy reaches patients far and wide. His cancer therapy instruction will focus on lung and breast cancer, recognizing them as the foremost contributors to global cancer-related mortality. This emphasis stems from the current scrutiny faced by existing treatments for their limited achievements, necessitating innovative approaches and advancements in the field. Unfortunately, this 2-year training program will restrict his availability to conduct SEF Chemo at our Berkeley clinic, but his commitment to spreading knowledge marks a new chapter in the fight against cancer, promising hope and progress on a global scale.
Welcome to Berkeley Institute International
Our international clinics are breaking through the barriers of conventional cancer care. With SEF Chemotherapy®, for the first time in history, we are putting the odds in favor of our patients.
MEDICAL REVOLUTION
SEF Chemo® is a revolution in modern medicine. With Side Effect Free chemotherapy, patients are able to receive a therapy with statistically unprecedented results, without the negative side effects experienced during traditional chemotherapy treatments.
FASTER AND MORE POWERFUL
SEF Chemo® is much safer and superior to conventional chemotherapy. Your immune system is not compromised during SEF Chemo treatments, enabling your body’s immune system to continue in the fight against cancerous cells. Therapy can be completed in as little as 16 weeks.
SAFE AND SIDE EFFECT FREE
Many patients experience horrible side effects from traditional chemotherapy, but with SEF Chemo®, you don’t have to. Side effects are mitigated, protecting the body’s immune system throughout the entire process. In fact, no patient has complained of hair loss, neuropathy, nor vomiting.
UNPARALLELED QUALITY OF CARE
Our clinics offer the most comprehensive care available. Our staff are trained to care for the physical, mental, and emotional well-being of the patient, and we spend as much time as necessary to achieve an unparalleled quality of care.
Meet Kenneth Matsumura
Kenneth Matsumura is a world-renowned scientist dedicated to solving some of the worlds most difficult problems. His inventions include, but are not limited to, The HeartAlarm™ wristwatch that gives it’s wearer early warning of an impending heart attack, SEF Chemo®, the bio-artificial liver that Time Magazine named Invention of the Year in 2001, and the bio-artificial pancreas that eliminates the need for daily injections.
He began his medical research at the age of 13. His first paper, on a new rapid skin-grafting technique was published in 1961, at the age of 15. And in 1962, he became the youngest person to ever receive a research grant from the American Lung Association. While his medical research and innovation are remarkable, they are matched only by his passion for social justice, equality, and philanthropic work.
Read more about him by clicking the link below.
OUR CLINICS
Our team of scientists and physicians at The Berkeley Institute International have been personally trained by Kenneth Matsumura to ensure all of our international clinics follow the exact protocols developed by Dr. Matsumura to provide revolutionary cancer care in 3 countries across the globe.
Holistic Care and Support
Dr. Matsumura has always put compassionate care above all other aspects of his clinic, and fully understands the difficulties placed on patients and their families. That’s why our staff is trained in complete, holistic physical and emotional care while patients receive therapy at the Berkeley Institute.